Role of Folate Antagonists in the Treatment of Methicillin-Resistant Staphylococcus aureus Infection
The DOI matches its Crossref record; 115 of the 115 references it cites were found in a registry or an index.
Abstract
Methicillin-resistant Staphylococcus aureus (MRSA) infection has reached epidemic proportions, and therapeutic options are limited because these strains are often multidrug resistant. However, the new strains of community-acquired MRSA show decreased resistance to trimethoprim-sulfamethoxazole. Clinical and experimental reports show a mixture of successes and failures with trimethoprim-sulfamethoxazole treatment. A reason for failure might be the amount of thymidine released from damaged host tissues and bacteria, a concept strengthened by the fact that S. aureus thermonuclease releases thymidine from DNA. Thus, success or failure with trimethoprim-sulfamethoxazole may well depend on the amount of tissue damage and organism burden, rather than acquisition of a resistance gene. Clinical trials and experimental animal studies show high failure rates, perhaps because of released thymidine. The use of trimethoprim-sulfamethoxazole for community-acquired MRSA infection should not be endorsed without further research.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The efficacy of trimethoprimsulfamethoxazole and other folate antagonists may be attenuated by thymidine release from damaged host cells (eg, at sites of tissue damage such as abscesses).166”
Citations
Cites
Infectious Diseases Society of America
Enders, J. F. (1969) · Journal of Infectious Diseases · doi:10.1093/infdis/119.3.317 · Cited by 3,286
Methicillin-Resistant S. aureus Infections among Patients in the Emergency Department
Moran, G. J., Krishnadasan, A., Gorwitz, R. J., Fosheim, G. E., McDougal, L. K., Carey, R. B., & Talan, D. A. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa055356 · Cited by 2,285 · cited 1×
“Thus, TMP-SMZ has been suggested for treatment of MRSA infection [13, 18, 19, 26, 27] because TMP-SMZ is inexpensive, is well tolerated, and penetrates well into tissues.”
BackgroundCosgrove, S. E., Sakoulas, G., Perencevich, E. N., Schwaber, M. J., Karchmer, A. W., & Carmeli, Y. (2003) · Clinical Infectious Diseases · doi:10.1086/345476 · Cited by 1,964
Practice Guidelines for the Diagnosis and Management of Skin and Soft-Tissue Infections
Stevens, D. L., Bisno, A. L., Chambers, H. F., Everett, E. D., Dellinger, P., Goldstein, E. J. C., Gorbach, S. L., Hirschmann, J. V., Kaplan, E. L., Montoya, J. G., et al. (2005) · Clinical Infectious Diseases · doi:10.1086/497143 · Cited by 1,602 · cited 1×
“Thus, TMP-SMZ has been suggested for treatment of MRSA infection [13, 18, 19, 26, 27] because TMP-SMZ is inexpensive, is well tolerated, and penetrates well into tissues.”
BackgroundSelf-citationProctor, R. A., von Eiff, C., Kahl, B. C., Becker, K., McNamara, P., Herrmann, M., & Peters, G. (2006) · Nature Reviews Microbiology · doi:10.1038/nrmicro1384 · Cited by 1,175
Self-citationEmergence of Vancomycin Resistance in Staphylococcus aureus
Smith, T. L., Pearson, M. L., Wilcox, K. R., Cruz, C., Lancaster, M. V., Robinson-Dunn, B., Tenover, F. C., Zervos, M. J., Band, J. D., White, E., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199902183400701 · Cited by 1,088
Hidayat, L. K., Hsu, D. I., Quist, R., Shriner, K. A., & Wong-Beringer, A. (2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.19.2138 · Cited by 860
Sakoulas, G., Moise-Broder, P. A., Schentag, J., Forrest, A., Moellering, R. C., & Eliopoulos, G. M. (2004) · Journal of Clinical Microbiology · doi:10.1128/jcm.42.6.2398-2402.2004 · Cited by 836
The benefit of appropriate empirical antibiotic treatment in patients with bloodstream infection
Leibovici, Shraga, Drucker, Konigsberger, Samra, Pitlik, & Pitlik (1998) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.1998.00379.x · Cited by 685
Levine, D. P., Fromm, B. S., & Reddy, B. R. (1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-115-9-674 · Cited by 577
Research works printed but not linked: 11
- Khawcharoenporn, 2006, Hawaii medical journal, 65, 290
- Markowitz, 1992, Annals of Internal Medicine, 117, 390, 10.1059/0003-4819-117-5-390 · doi:10.1059/0003-4819-117-5-390
- 1939, Lancet, 2, 1065
- 1939, INTL CLINICS, 4, 1
- 1938, Lancet, 2, 1233
- 1938, Lancet, 2, 1232
- TORREY, 1941, Annals of Internal Medicine, 15, 431, 10.1059/0003-4819-15-3-431 · doi:10.1059/0003-4819-15-3-431
- 1939, Lancet, 1, 756
- McDowell, 1991, Clinical laboratory science : journal of the American Society for Medical Technology, 4, 299
- FINLAND, 1942, Annals of Internal Medicine, 17, 920, 10.1059/0003-4819-17-6-920 · doi:10.1059/0003-4819-17-6-920
- Levine, 1991, Annals of Internal Medicine, 115, 674, 10.1059/0003-4819-115-9-674 · doi:10.1059/0003-4819-115-9-674
Cited by
Items 101–138 of 138
Updates on Combination Therapy for Methicillin-Resistant Staphylococcus aureus Bacteremia
Blackman, A. L., Rubin, E. C., Broadbent, E. K., & Brade, K. D. (2020) · Current Infectious Disease Reports · doi:10.1007/s11908-020-00737-8 · Cited by 5
Kerstin, A. W., Sherman, M., & Nguye, L. (2011) · InTech eBooks · doi:10.5772/27702 · Cited by 6
Draper, H. M., Rybak, M. J., LaPlante, K. L., Lodise, T. P., Sakoulas, G., Burk, M. L., & Cunningham, F. E. (2024) · American Journal of Health-System Pharmacy · doi:10.1093/ajhp/zxae163 · Cited by 3
Community-Associated Methicillin-Resistant Staphylococcus aureus
Miller, L. G., & Eells, S. J. (2014) · ASM Press eBooks · doi:10.1128/9781555815592.ch12 · Cited by 3
Robinson, J. L., & Salvadori, M. I. (2011) · Paediatrics & Child Health · doi:10.1093/pch/16.2.117 · Cited by 3
Oral Agents for the Treatment of Orthopedic Infections Caused by Methicillin-resistant Staphylococci
Kim, B.-N. (2011) · Infection and Chemotherapy · doi:10.3947/ic.2011.43.4.322 · Cited by 3
Modern Antibiotic Treatment of Chronic Long Bone Infections in Adults-Theory, Evidence and Practice
Deabate, L., PAGANI, L., & UÇKAY, İ. (2014) · DOAJ (DOAJ: Directory of Open Access Journals) · Cited by 3
Drawbacks of the use of cotrimoxazole in foreign-body infections
Haj, C. E., Ribera, A., Lloberas, N., Tubau, F., Ariza, J., & Murillo, Ó. (2017) · Enfermedades Infecciosas y Microbiología Clínica · doi:10.1016/j.eimc.2017.07.005 · Cited by 3
Treatment of Staphylococcal Infections
Crossley, K., & John, J. F. (2009) · Wiley eBooks · doi:10.1002/9781444308464.ch31 · Cited by 4
De novo or Salvage? Nucleotide Availability as a Driver of Bacterial Adaptation and Virulence
Joshi, R., McEwan, A. G., & Kappler, U. (2026) · MicrobiologyOpen · doi:10.1002/mbo3.70358 · Cited by 3
Bhardwaj, D., Tiwari, D., Upadhye, V. J., Ramniwas, S., Rautela, I., Ballal, S., Kumar, S., Bhat, M., Sharma, S., Kumar, M., et al. (2024) · Current Pharmaceutical Biotechnology · doi:10.2174/0113892010344474241011070242 · Cited by 3
Sadeghi, H., Ahmadi, F., McArthur, E., Sontrop, J. M., Abdullah, S. S., Urquhart, B. L., Kim, R. B., & Muanda, F. T. (2024) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.16365 · Cited by 2
Barberán, J., Varona, J. F., & Tejeda, M. I. (2014) · Medicine - Programa de Formación Médica Continuada Acreditado · doi:10.1016/s0304-5412(14)70803-0 · Cited by 2
Vedia, L. D., Furst, M. J. L., Scapellato, P. G., Lopardo, G. D., Clara, L., & Lista, N. (2023) · Actualizaciones en Sida e Infectología · doi:10.52226/revista.v22i85.265 · Cited by 2
Community-associated Staphylococcus aureus infections: pneumonia
Karvouniaris, M., Makris, D. A., & Zakynthinos, E. G. (2010) · Microbiology Research · doi:10.4081/mr.2010.e4 · Cited by 5
“For example, in the case of a lung abscess, TMP/SMX treatment was associated with a higher rate of failures compared to vancomycin.(56) Clindamycin can work in an environment with a high bacterial burden, has anti-PVL activity, and is cheap.”
BackgroundUçkay, İ., Al‐Mayahi, M., Suvà, D., Lew, D., & Vaudaux, P. E. (2015) · Wiley eBooks · doi:10.1002/9781118581742.ch6 · Cited by 2
Pyrimidine nucleoside: inspiration for novel antimicrobial agent
Xu, B., Li, P., Liu, J., & Li, M. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1773361 · Cited by 1
“Compound 15 (Floxuridine, Figure 3) is a commonly used fluoropyrimidine antitumor drug in clinical practice (Myers et al., 1976; Proctor, 2008).”
Nolan, A. C., Kelly, J. B., Ahn, J., Shinde, D., Thomas, V. C., Zeden, M. S., & O’Gara, J. P. (2026) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00377-26 · Cited by 1
“These drugs target sequential enzymes in folate synthesis that feed into thymidine production (45–47), but their effectiveness is undermined by resistance associated with mutations in dfrB and thyA (8, 48–50).”
Bach, T. H., Hsu, D. I., & Bounthavong, M. (2011) · Clinical Medicine Reviews in Therapeutics · doi:10.4137/cmrt.s1572 · Cited by 1
Infeccions emergents atribuïdes a la resistència antibiòtica
Roig, A. M. (2011) · Pediatria catalana: butlletí de la Societat Catalana de Pediatria · Cited by 1
Oral treatment of acute pyelonephritis: when, with which antimicrobial agent and for how long?
Pigrau, C., & Escolà‐Vergé, L. (2020) · Enfermedades Infecciosas y Microbiología Clínica · doi:10.1016/j.eimc.2020.05.009 · Cited by 1
Drawbacks of the use of cotrimoxazole in foreign-body infections
Haj, C. E., Ribera, A., Lloberas, N., Tubau, F., Ariza, J., & Murillo, Ó. (2018) · Enfermedades infecciosas y microbiologia clinica (English ed ) · doi:10.1016/j.eimce.2017.07.004 · Cited by 1
Taghipour, A., Rafie, S. M., Masouleh, M. N., & Mortazavi, S. P. (2018) · Comparative Clinical Pathology · doi:10.1007/s00580-018-2774-6 · Cited by 1
“Although bone has good immunity against infectious agents, some factors such as weak immune system, inflammation, and the reduction of proper perfusion to the affected area and the presence of foreign bodies predispose for the disease (Anwar et al. 1990; Goldstein and Proctor 2008; Plumb 2011).”
BackgroundCephalexin remains the preferred antibiotic for uncomplicated cellulitis: revisited
Cunha, B. A. (2014) · Journal of Chemotherapy · doi:10.1179/1973947814y.0000000170 · Cited by 1
Reply to “Susceptibility of Streptococcus pyogenes to Trimethoprim-Sulfamethoxazole”
Bowen, A. C., Tong, S. Y. C., & Carapetis, J. R. (2013) · Journal of Clinical Microbiology · doi:10.1128/jcm.03373-12 · Cited by 1
Subcutaneous Tissue Infections and Abscesses
Woods, C. R. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-75608-2.00073-2 · Cited by 1
Staphylococcal and Enterococcal Infections
Graber, C. J., & Schaberg, D. R. (2009) · Humana Press eBooks · doi:10.1007/978-1-60327-534-7_21
SCV'S: FORMATION AND CHARACTERISATION IN STAPHYLOCOCCUS SP
Alharbi, N. S. H. A. (2013) · ORCA Online Research @Cardiff (Cardiff University) · Cited by 1
Why not performing susceptibility test for trimethoprim-sulphamethoxazole?
Hagiya, H. (2014) · Journal of Chemotherapy · doi:10.1179/1973947814y.0000000215
Jones, R. N., Biedenbach, D. J., & Sader, H. S. (2009) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2008.04.002
Lilly, E. A., Ikeh, M. A. C., Fidel, P. L., & Noverr, M. C. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.01.21.914200
Jin, W., Lin, W., Feng, Q., Zhang, D., Yang, J., & Qin, A. (2020) · doi:10.21203/rs.3.rs-80176/v1
“Proctor proposes that the special thermonuclease in SA could release extra thymidine from bacterial inoculum and mammalian tissues, so they can bypass the metabolic blockades caused by co-trimoxazole [25].”
Background(2009) · Current Opinion in Otolaryngology & Head & Neck Surgery · doi:10.1097/moo.0b013e32832406ce
Oral treatment of acute pyelonephritis: when, with which antimicrobial agent and for how long?
Pigrau, C., & Escolà‐Vergé, L. (2020) · Enfermedades infecciosas y microbiologia clinica (English ed ) · doi:10.1016/j.eimce.2020.05.002
Ariane, G., Rachel, H., Lévesque, S., Nathalie, B., Capistran, È., Vincent, M., & Martin, P. (2026) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2026.117439
Selim, A. A. M. A. (2026) · Natural Product Research · doi:10.1080/14786419.2026.2674712
Metadata
- Authors
- Goldstein, E. J. C., & Proctor, R. A.
- Affiliations
- University of Wisconsin–Madison (US)
- Corresponding author
- Proctor, R. A.
- ORCID
- Proctor, R. A.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2008-02-15
- Volume
- 46
- Issue
- 4
- Pages
- 584-593
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2087260740
- Semantic Scholar
- f78fb0266126827966c2fc1286d2a500166b4fb5
- Cited by
- 138
- References
- 115
- Citations by year
- 2026: 5 · 2025: 1 · 2024: 5 · 2023: 4 · 2022: 3 · 2021: 2 · 2020: 5 · 2019: 3 · 2018: 6 · 2017: 6 · 2016: 2 · 2015: 5 · 2014: 14 · 2013: 7 · 2012: 11
- FWCI
- 2.28
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Infectious Diseases (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antimicrobial Resistance in Staphylococcus
- Health Sciences › Medicine › Infectious Diseases › Antibiotic Use and Resistance
- Health Sciences › Medicine › Infectious Diseases › Streptococcal Infections and Treatments
- Keywords
- methicillin-resistant Staphylococcus aureus, trimethoprim-sulfamethoxazole, antifolate, thermonuclease, community-acquired MRSA, multidrug resistance, antibiotic treatment failure, tissue damage
- MeSH terms
- Animals, Anti-Infective Agents, Humans, Staphylococcal Infections, Staphylococcus aureus, Trimethoprim, Sulfamethoxazole Drug Combination, Methicillin Resistance, Community-Acquired Infections
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.